Free Trial

Vaxxinity (VAXX) Competitors

Vaxxinity logo
$0.02 +0.01 (+50.00%)
As of 09:46 AM Eastern

VAXX vs. ADTX, SMFL, SCPS, EVLO, GNCAQ, GNCA, ARDS, STAB, AMPE, and CALA

Should you be buying Vaxxinity stock or one of its competitors? The main competitors of Vaxxinity include Aditxt (ADTX), Smart for Life (SMFL), Scopus BioPharma (SCPS), Evelo Biosciences (EVLO), Genocea Biosciences (GNCAQ), Genocea Biosciences (GNCA), Aridis Pharmaceuticals (ARDS), Statera Biopharma (STAB), Ampio Pharmaceuticals (AMPE), and Calithera Biosciences (CALA). These companies are all part of the "pharmaceutical products" industry.

Vaxxinity vs.

Vaxxinity (NASDAQ:VAXX) and Aditxt (NASDAQ:ADTX) are both small-cap medical companies, but which is the superior business? We will compare the two companies based on the strength of their profitability, community ranking, media sentiment, valuation, earnings, institutional ownership, analyst recommendations, risk and dividends.

82.9% of Vaxxinity shares are held by institutional investors. Comparatively, 15.5% of Aditxt shares are held by institutional investors. 64.1% of Vaxxinity shares are held by company insiders. Comparatively, 0.0% of Aditxt shares are held by company insiders. Strong institutional ownership is an indication that hedge funds, endowments and large money managers believe a company will outperform the market over the long term.

Aditxt has higher revenue and earnings than Vaxxinity.

CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings Ratio
VaxxinityN/AN/A-$56.93M-$0.45-0.03
Aditxt$133.99K0.77-$32.38MN/AN/A

Vaxxinity has a beta of -22.53, indicating that its share price is 2,353% less volatile than the S&P 500. Comparatively, Aditxt has a beta of 1.6, indicating that its share price is 60% more volatile than the S&P 500.

Vaxxinity received 1 more outperform votes than Aditxt when rated by MarketBeat users. However, 44.44% of users gave Aditxt an outperform vote while only 38.46% of users gave Vaxxinity an outperform vote.

CompanyUnderperformOutperform
VaxxinityOutperform Votes
5
38.46%
Underperform Votes
8
61.54%
AditxtOutperform Votes
4
44.44%
Underperform Votes
5
55.56%

Vaxxinity's return on equity of 0.00% beat Aditxt's return on equity.

Company Net Margins Return on Equity Return on Assets
VaxxinityN/A N/A N/A
Aditxt N/A -439.07%-122.96%

In the previous week, Aditxt had 5 more articles in the media than Vaxxinity. MarketBeat recorded 5 mentions for Aditxt and 0 mentions for Vaxxinity. Aditxt's average media sentiment score of 1.52 beat Vaxxinity's score of 0.00 indicating that Aditxt is being referred to more favorably in the news media.

Company Overall Sentiment
Vaxxinity Neutral
Aditxt Very Positive

Summary

Aditxt beats Vaxxinity on 6 of the 11 factors compared between the two stocks.

Get Vaxxinity News Delivered to You Automatically

Sign up to receive the latest news and ratings for VAXX and its competitors with MarketBeat's FREE daily newsletter.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding {thisCompany.Symbol} and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.
Skip Chart

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.
Skip Chart

VAXX vs. The Competition

MetricVaxxinityPharmaceutical IndustryMedical SectorNASDAQ Exchange
Market Cap$1.90M$6.48B$5.33B$8.39B
Dividend YieldN/A2.64%5.21%4.11%
P/E Ratio-0.039.0626.7119.71
Price / SalesN/A251.50386.13120.55
Price / CashN/A65.8538.2534.62
Price / Book0.146.456.774.50
Net Income-$56.93M$143.98M$3.23B$248.22M
7 Day PerformanceN/A2.41%1.80%0.56%
1 Month PerformanceN/A4.56%11.10%13.17%
1 Year PerformanceN/A-2.67%17.11%7.30%

Vaxxinity Competitors List

CompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)
VAXX
Vaxxinity
N/A$0.02
+50.0%
N/A-88.0%$1.90MN/A-0.0390Gap Up
High Trading Volume
ADTX
Aditxt
0.8733 of 5 stars
$1.63
-8.9%
N/A-100.0%$93,000.00$133,985.000.0060Positive News
Earnings Report
Gap Up
SMFL
Smart for Life
N/A$0.00
-82.9%
N/A-100.0%$21,000.00$11.11M0.00110Gap Up
High Trading Volume
SCPS
Scopus BioPharma
N/A$0.00
flat
N/AN/A$13,000.00N/A0.009
EVLO
Evelo Biosciences
N/A$0.00
flat
N/AN/A$6,000.00N/A0.00120Gap Up
GNCAQ
Genocea Biosciences
N/AN/AN/AN/A$6,000.00N/A0.0070
GNCA
Genocea Biosciences
N/AN/AN/AN/A$6,000.00$1.91M0.0070Analyst Forecast
ARDS
Aridis Pharmaceuticals
N/A$0.00
flat
N/A-99.8%$5,000.00$3.09M0.0030
STAB
Statera Biopharma
N/A$0.00
flat
N/A-85.7%$5,000.00N/A0.0020
AMPE
Ampio Pharmaceuticals
N/A$0.00
+11.1%
N/A-98.8%$3,000.00N/A0.0020Gap Up
CALA
Calithera Biosciences
N/A$0.00
+500.0%
N/A-97.0%$3,000.00N/A0.0060Analyst Forecast

Related Companies and Tools


This page (NASDAQ:VAXX) was last updated on 5/22/2025 by MarketBeat.com Staff
From Our Partners